Maastricht 2017 Meeting Highlights Registration Programme Overview Exhibition Virtual Exhibition Hotels Satellite Meetings Visa Letter Application Star Alliance Travel Discount
title

10 - 12 February 2017, MECC Maastricht,The Netherlands.

This Meeting has been awarded 15 CME credits.

Posters

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Evaluation of a preloaded, aspheric and hydrophobic intraocular lens (IOL) platform for implantation without the use of OVD

Poster Details


First Author: F. Kretz GERMANY

Co Author(s): M. Mueller   D. Breyer   H. Kaymak   K. Klabe   G. Auffarth   M. Gerl     

Abstract Details

Purpose:

To evaluate the functional outcome after implantation of a new aspheric intraocular lens (IOL) with a novel platform design, special surface properties and its application through an enhanced injector with balanced salt solution (BSS) only, to provide better intraocular stability.

Setting:

Augenklinik Ahaus, Germany; International Vision Correction research Centre Network, Univ. of Heidelberg

Methods:

Examinations three months after surgery included manifest refraction, UDVA, and CDVA [logMAR] as well as usability of the enhanced injector during implantation. All IOLs were implanted through a 2.2mm incision using docking technique with the irrigation handpiece for constant BSS infusion during implantation.

Results:

Mean UDVA increased from 0,5 to 0,2 logMAR 3 months postoperatively. Mean CDVA was 0,0 logMAR postoperatively. The injector was very easy to handle. Because of the enhanced injector design there was no tip blooming effect of the silicon cushion.

Conclusions:

The new aspheric hydrophobic IOL shows a very good centration and is very easy to implant. Postoperative refraction is stable with a high amount of patient satisfaction

Financial Disclosure:

receives consulting fees, retainer, or contract payments from a company producing, developing or supplying the product or procedure presented, travel has been funded, fully or partially, by a competing company, travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, research is funded, fully or partially, by a competing company, research is funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, receives consulting fees, retainer, or contract payments from a competing company

Back to Poster listing